drugset / Trial / NCT01405521

Understanding Typhoid Disease After Vaccination

NCT01405521 ↗

RandomizedParallel-groupQuadruple-blindPrevention

Summary

Using an established model of human typhoid infection, whereby healthy adults are deliberately infected with typhoid-causing bacteria, the investigators will determine how effective a new oral typhoid vaccine (M01ZH09) is in preventing infection. A previously licensed oral typhoid vaccine (Ty21a) will be used to make sure the challenge model used works properly.

Timeline

Start
2011-10-07
Primary completion
2015-12
Completion
2022-05-06

Outcome

Missed primary endpoint

paper single-dose M01ZH09 failed to demonstrate significant protection after challenge with virulent Salmonella Typhi in this model. PMID 27533046 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject M01ZH09 Vaccine — Oral
Subject Ty21a Vaccine — Oral

Indications